Allworth Financial’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Buy
2,339
+927
+66% +$7.76K ﹤0.01% 3216
2026
Q1
$11.7K Buy
1,412
+798
+130% +$8.27K ﹤0.01% 3394
2025
Q4
$7.59K Buy
614
+165
+37% +$1.77K ﹤0.01% 3443
2025
Q3
$3.96K Buy
449
+374
+499% +$2.91K ﹤0.01% 3682
2025
Q2
$479 Buy
+75
New +$429 ﹤0.01% 4149
2023
Q3
– Sell
-21
Closed -$155 – 3467
2023
Q2
$155 Buy
+21
New +$195 ﹤0.01% 3137
2023
Q1
– Sell
-92
Closed -$1.09K – 3227
2022
Q4
$1.09K Buy
92
+85
+1,214% +$1.31K ﹤0.01% 2445
2022
Q3
$0 Buy
7
+1
+17% +$28 ﹤0.01% 2768
2022
Q2
$0 Buy
6
+2
+50% +$68 ﹤0.01% 2497
2022
Q1
$0 Sell
4
-191
-98% -$8.42K ﹤0.01% 2180
2021
Q4
$8K Buy
+195
New +$8.82K ﹤0.01% 1463
2021
Q3
– Sell
-130
Closed -$8K – 1895
2021
Q2
$8K Hold
130
– – ﹤0.01% 1094
2021
Q1
$12K Hold
130
– – ﹤0.01% 930
2020
Q4
$12K Hold
130
– – ﹤0.01% 787
2020
Q3
$13K Hold
130
– – ﹤0.01% 650
2020
Q2
$10K Hold
130
– – ﹤0.01% 723
2020
Q1
$8K Buy
+130
New +$7.49K ﹤0.01% 744

Other funds holding EBS

Allworth Financial's EBS Position: Q2 2026 in Review

Allworth Financial increased its Emergent Biosolutions (EBS) stake by 66% in Q2 2026, buying an estimated $7.76K and bringing the position to 2,339 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

Allworth Financial first reported a position in EBS in Q1 2020 and has held it in 17 quarters since. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Allworth Financial held 2,339 shares of Emergent Biosolutions worth $19.6K as of Q2 2026.
  • Allworth Financial bought 927 Emergent Biosolutions shares in Q2 2026, an estimated $7.76K.
  • Emergent Biosolutions made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3216 holding.
  • Allworth Financial first reported a position in Emergent Biosolutions in Q1 2020 and has held it in 17 quarters since.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.